The cervix cancer research network: Increasing access to cancer clinical trials in low- and middle-income countries

Frontiers in Oncology

Volumn 5, Issue FEB, 2015, Pages

  Suneja, Gita ^a   Bacon, Monica ^b   Small, William ^c   Ryu, Sang Y ^d   Kitchener, Henry C ^e   Gaffney, David K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Gynecologic Cancer InterGroup (GCIG)   (Canada)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d Chonnam National University Medical School   (South Korea)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cervix cancer; Clinical trials as topic; Global health; HIV cancer; Radiation oncology

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); HUMAN; LOWEST INCOME GROUP; MIDDLE INCOME GROUP; OPTICALLY STIMULATED LUMINESCENCE DOSIMETRY; OVARY CANCER; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY CONTROL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL STATUS; UTERINE CERVIX CANCER;

EID: 84923260934     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2015.00014     Document Type: Article

References (15)

1. GLOBOCAN Data. (2014). Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx
2. Sankaranarayanan R. Overview of cervical cancer in the developing world. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet (2006) 95(Suppl 1):S205-10. doi: 10.1016/S0020-7292(06)60035-0
3. Parkhurst JO, Vulimiri M. Cervical cancer and the global health agenda: insights from multiple policy-analysis frameworks. Glob Public Health (2013) 8(10):1093-108. doi:10.1080/17441692.2013.850524
4. Krishnan S, Madsen E, Porterfield D, Varghese B. Advancing cervical cancer prevention in India: implementation science priorities. Oncologist (2013) 18(12):1285-97. doi:10.1634/theoncologist.2013-0292
5. Diaz M, Kim JJ, Albero G, de Sanjosé S, Clifford G, Bosch FX, et al. Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer (2008) 99(2):230-8. doi:10.1038/sj.bjc.6604462
6. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer v 2. (2013). Available from: http://www.nccn.org
7. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol (2004) 22(5):872-80. doi:10.1200/JCO.2004.07.197
8. Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnston D, Lukka H, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol (2002) 20(4):966-72. doi:10.1200/JCO.20.4.966
9. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med (1999) 340(15):1144-53. doi:10.1056/NEJM199904153401502
10. Peters WA, Liu PY, Barrett RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol (2000) 18(8):1606-13.
11. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin (2014) 64(1):9-29. doi:10.3322/caac.21208
12. Ryu S-Y, Lee WM, Kim K, Park SI, Kim BJ, Kim MH, et al. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2011) 81(4):e577-81. doi:10.1016/j.ijrobp.2011.05.002
13. Wang N, Guan QL, Wang K, Zhou X, Gao C, Yang HT, et al. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis. Arch Gynecol Obstet (2011) 283(1):103-8. doi:10.1007/s00404-010-1385-5
14. Emanuel EJ, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical? The benchmarks of ethical research. J Infect Dis (2004) 189(5):930-7. doi:10.1086/381709
15. Joffe S, Miller FG. Ethics of cancer clinical trials in low-resource settings. J Clin Oncol (2014) 32(28):3192-6. doi:10.1200/JCO.2014.56.9780